Current status of therapeutic monoclonal antibodies against SARS-CoV-2

被引：70
|
作者：
Kumar, Sanjeev [1 ]
Chandele, Anmol [1 ]
Sharma, Amit [2 ,3 ]
机构：
[1] Int Ctr Genet Engn & Biotechnol, ICGEB Emory Vaccine Ctr Program, New Delhi, India
[2] Int Ctr Genet Engn & Biotechnol, Struct Parasitol Grp, New Delhi, India
[3] Natl Inst Malaria Res, New Delhi, India
来源：
PLOS PATHOGENS | 2021年 / 17卷 / 09期
基金：
英国惠康基金;
关键词：
D O I：
10.1371/journal.ppat.1009885
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
AMP Exception</p>
引用
收藏
页数：8
相关论文
共 50 条
  • [41] Identification and Analysis of Monoclonal Antibodies with Neutralizing Activity against Diverse SARS-CoV-2 Variants
    Ishimaru, Hanako
    Nishimura, Mitsuhiro
    Tjan, Lidya Handayani
    Sutandhio, Silvia
    Marini, Maria Istiqomah
    Effendi, Gema Barlian
    Shigematsu, Hideki
    Kato, Koji
    Hasegawa, Natsumi
    Aoki, Kaito
    Kurahashi, Yukiya
    Furukawa, Koichi
    Shinohara, Mai
    Nakamura, Tomoka
    Arii, Jun
    Nagano, Tatsuya
    Nakamura, Sachiko
    Sano, Shigeru
    Iwata, Sachiyo
    Okamura, Shinya
    Mori, Yasuko
    JOURNAL OF VIROLOGY, 2023, 97 (06) : e0028623
  • [42] Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused
    Gentile, Ivan
    Maraolo, Alberto Enrico
    Buonomo, Antonio Riccardo
    Nobile, Mariano
    Piscitelli, Prisco
    Miani, Alessandro
    Schiano Moriello, Nicola
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (21)
  • [43] SARS-CoV-2 Vaccine Development: Current Status
    Poland, Gregory A.
    Ovsyannikova, Inna G.
    Crooke, Stephen N.
    Kennedy, Richard B.
    MAYO CLINIC PROCEEDINGS, 2020, 95 (10) : 2172 - 2188
  • [44] SARS-CoV-2 spike therapeutic antibodies in the age of variants
    Baum, Alina
    Kyratsous, Christos A.
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (05):
  • [45] Current state of vaccination against SARS-CoV-2
    Iking-Konert, Christof
    Specker, Christof
    Krueger, Klaus
    Schulze-Koops, Hendrik
    Aries, Peer
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (02): : 158 - 164
  • [46] Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization
    Klasse, P. J.
    Moore, John P.
    ELIFE, 2020, 9
  • [47] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [48] Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Yu, Fei
    Xiang, Rong
    Deng, Xiaoqian
    Wang, Lili
    Yu, Zhengsen
    Tian, Shijun
    Liang, Ruiying
    Li, Yanbai
    Ying, Tianlei
    Jiang, Shibo
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [49] Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
    Fei Yu
    Rong Xiang
    Xiaoqian Deng
    Lili Wang
    Zhengsen Yu
    Shijun Tian
    Ruiying Liang
    Yanbai Li
    Tianlei Ying
    Shibo Jiang
    Signal Transduction and Targeted Therapy, 5
  • [50] A systematic review of current status and challenges of vaccinating children against SARS-CoV-2
    Zhang, Mengxin
    Zhang, Pin
    Liang, Ying
    Du, Bang
    Li, Lifeng
    Yu, Zhidan
    Wang, Huanmin
    Wang, Qionglin
    Zhang, Xianwei
    Zhang, Wancun
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2022, 15 (11) : 1212 - 1224
12345